Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gascon

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)M Aapro, A Molassiotis, M Dicato, et al.
Blood|October 25, 2001
Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic studyD D Joshi, A Dang, P Yadav, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human bloodM J Dobersen, P Gascon, S Trost, et al.
Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.
Cancer|March 15, 1993
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14R M Sharkey, D M Goldenberg, S Murthy, et al.
Oncology|August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapyM Martin-Richard, M Muñoz, J Albanell, et al.
Critical Care Medicine|June 1, 1995
Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsisR Porat, H N Paddock, S D Schwaitzberg, et al.
Oncology|July 16, 2005
Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCRJ Domingo-Domènech, R Molina, T Castel, et al.
British Journal of Cancer|September 17, 2009
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancerB Mellado, A Font, A Alcaraz, et al.
Endocrine-Related Cancer|May 27, 2006
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patientsC Montagut, I Tusquets, B Ferrer, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)M Aapro, A Molassiotis, M Dicato, et al.
Blood|October 25, 2001
Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic studyD D Joshi, A Dang, P Yadav, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human bloodM J Dobersen, P Gascon, S Trost, et al.
Cancer|February 1, 1994
Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomasR M Sharkey, D M Goldenberg, R Vagg, et al.
Cancer|March 15, 1993
Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14R M Sharkey, D M Goldenberg, S Murthy, et al.
Oncology|August 28, 2004
Serial topoisomerase II expression in primary breast cancer and response to neoadjuvant anthracycline-based chemotherapyM Martin-Richard, M Muñoz, J Albanell, et al.
Critical Care Medicine|June 1, 1995
Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsisR Porat, H N Paddock, S D Schwaitzberg, et al.
Oncology|July 16, 2005
Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCRJ Domingo-Domènech, R Molina, T Castel, et al.
British Journal of Cancer|September 17, 2009
Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancerB Mellado, A Font, A Alcaraz, et al.
Endocrine-Related Cancer|May 27, 2006
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patientsC Montagut, I Tusquets, B Ferrer, et al.
Pageof 10